Geron’s Imetelstat Faces Full Gamut Of US FDA Questions At ODAC Meeting

 
• By Derrick Gingery
blood transfusion
The imetelstat advisory committee documents included separate briefings from the FDA and Geron, rather than a combined package. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers